08:12 ET ISIS Pharma and ITRI to initiate SARS drug discovery effort (ISIS) 5.02: Announces that Industrial and Technology Research Institute of Taiwan announced today that they will collaborate to identify antisense drug candidates targeting the coronavirus associated with Severe Acute Respiratory Syndrome (SARS). Under the agreement, Isis will conduct the antisense drug discovery research and I.T.R.I. will provide $2 mln in initial funding to initiate the collaboration, with the potential for further funding.
Market Data 
Markets 
AI
